Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease

Clinical Science

Volumn 124, Issue 1, 2013, Pages 41-51

  Royce, Simon G ^a   Sedjahtera, Amelia ^a   Samuel, Chrishan S ^b,c,d   Tang, Mimi L K ^a,c,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Airway remodelling; Allergic airways disease; Asthma; Corticosteroid; Relaxin

Indexed keywords

COLLAGEN; METHYLPREDNISOLONE; RELAXIN; OVALBUMIN; RLN2 PROTEIN, HUMAN;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DRUG COMBINATION; EPITHELIUM; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG LAVAGE; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY;

AIRWAY REMODELING; ANIMALS; BRONCHOALVEOLAR LAVAGE; DRUG THERAPY, COMBINATION; EPITHELIUM; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; METHYLPREDNISOLONE; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY FIBROSIS; RELAXIN; RESPIRATORY HYPERSENSITIVITY; STATISTICS, NONPARAMETRIC;

EID: 84871690183     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120024     Document Type: Article

References (60)

1. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M. and Vignola, A. M. (2000) Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720-1745
2. Holgate, S. T. (2008) Pathogenesis in asthma. Clin. Exp. Allergy 38, 872-897
3. O'Byrne, P. M. and Inman, M. D. (2003) Airway hyperresponsiveness. Chest 123, 411S-416S
4. Panickar, J., Lakhanpaul, M., Lambert, P. C., Kenia, P., Stephenson, T., Smyth, A. and Grigg, J. (2009) Oral steroids ineffective in the treatment of preschool virus-induced wheezing. N. Engl. J. Med. 360, 329-338
5. Vignola, A. M., Chanez, P., Siena, L., Chiappara, G., Bonsignore, G. and Bousquet, J. (1998) Airways remodelling in asthma. Pulmon. Pharmacol. Ther. 11, 359-367
6. Lazaar, A. L. and Panettieri, R. A. (2003) Is airway remodelling clinically relevant in asthma? Am. J. Med. 115, 652-659
7. Pascual, R. M. and Peters, S. P. (2005) Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J. Allergy Clin. Immunol. 116, 477-486
8. Payne, D. N. R., Rogers, A. V., Ädelroth, E., Bandi, V., Guntupalli, K. K., Bush, A. and Jeffery, P. K. (2003) Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 176, 78-82
9. Barnes, P. J. (2006) How corticosteroids control inflammation: Br. J. Pharmacol. 148, 245-254
10. Tomkowicz, A., Kraus-Filarska, M., Bar, J., Rabczyński, J., Jeleń, M., Piesiak, P., Fal, A. and Panaszek, B. (2008) Bronchial hyper-responsiveness, subepithelial fibrosis and transforming growth factor-ß1 expression in patients with long-standing and recently diagnosed asthma. Arch. Immunol. Ther. Exp. 56, 401-408
11. Hoshino, M., Takahashi, M., Takai, Y. and Sim, J. (1999) Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 104, 356-363
12. Trifilieff, A., El-Hashim, A. and Bertrand, C. (2000) Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1120-L1128
13. James, A. (2004) Airway remodeling in asthma. Curr. Opin. Pulmon. Med. 11, 1-6
14. Lipworth, B. J. (1999) Systemic adverse effects of inhaled corticosteroid therapy. Arch. Int. Med. 159, 941-955
15. Adcock, I. M. and Lane, S. J. (2003) Corticosteroid-insensitive asthma: molecular mechanisms. Endocrinology 178, 347-355
16. Samuel, C. S. (2005) Relaxin: antifibrotic properties and effects in model of disease. Clin. Med. Res. 3, 241-249
17. Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M. and Sherwood, O. D. (2002) Activation of orphan receptors by the hormone relaxin. Science 295, 671-674
18. Bathgate, R. A., Ivell, R. and Sanborn, B. M. (2006) International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 58, 7-31
19. Bennett, R. G. (2009) Relaxin and its role in the development and treatment of fibrosis. Transl. Res. 154, 1-6
20. Lekgabe, E. D., Royce, S. G., Hewitson, T. D., Tang, M. L., Zhao, C., Moore, X. L., Tregear, G. W., Bathgate, R. A., Du, X. J. and Samuel, C. S. (2006) The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology 147, 5575-5583
21. Mookerjee, I., Solly, N. R., Royce, S. G., Tregear, G. W., Samuel, C. S. and Tang, M. L. (2006) Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology 147, 754-761
22. Samuel, C. S., Zhao, C., Bathgate, R. A., Bond, C. P., Burton, M. D., Parry, L. J., Summers, R. J., Tang, M. L., Amento, E. P. and Tregear, G. W. (2003) Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J. 17, 121-123
23. Samuel, C. S., Royce, S. G., Chen, B., Cao, H., Gossen, J. A., Tregear, G. W. and Tang, M. L. (2009) Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease. Endocrinology 150, 1495-1502
24. Royce, S. G., Miao, Y. R., Lee, M., Samuel, C. S., Tregear, G. W. and Tang, M. L. (2009) Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease. Endocrinology 150, 2692-2699
25. Dschietzig, T., Bartsch, C., Stangl, V., Baumann, G. and Stangl, K. (2004) Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J. 18, 1536-1538
26. Melgert, B. N., Postma, D. S., Kuipers, I., Geerlings, M., Luinge, M. A., van der Strate, B. W., Kerstjens, H. A., Timens, W. and Hylkema, M. N. (2005) Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin. Exp. Allergy 35, 1496-1503
27. Locke, N. R., Royce, S. G., Wainewright, J. S., Samuel, C. S. and Tang, M. L. (2007) Comparison of airway remodeling in acute, subacute, and chronic models of allergic airway disease. Am. J. Respir. Cell Mol. Biol. 36, 625-632
28. Reference deleted
29. Hoshino, M., Nakamura, Y., Sim, J., Shimojo, J. and Isogai, S. (1998) Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. Allergy Clin. Immunol. 1998, 783-788
30. Martin, T. R., Gerard, N. P., Galli, S. J. and Drazen, J. M. (1988) Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64, 2318-2323
31. Samuel, C. S., Royce, S. G., Burton, M. D., Zhao, C., Tregear, G. W. and Tang, M. L. (2007) Relaxin plays an important role in the regulation of airway structure and function. Endocrinology 148, 4259-4266
32. Zhao, L., Samuel, C. S., Tregear, G. W., Beck, F. and Wintour, E. M. (2000) Collagen studies in late pregnant relaxin null mice. Biol. Reprod. 63, 697-703
33. Ivell, R., Balvers, M., Pohnke, Y., Telgmann, R., Bartsch, O., Milde-Langosch, K., Bamberger, A. M. and Einspanier, A. (2003) Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod. Biol. Endocrinol. 1, 114
34. Temelkovski, J., Hogan, S. P., Shepherd, D. P., Foster, P. S. and Kumar, R. K. (1998) An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53, 849-856
35. Samuel, C. S., Mookerjee, I. and Lekgabe, E. D. (2005) Actions of relaxin on non-reproductive tissue. Curr. Medicinal Chem. 5, 391-402
36. Chakir, J., Laviolette, M., Boutet, M., Laliberte, R., Dube, J. and Boulet, L. P. (1996) Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab. Invest. 75, 735-744
37. Shiba, K., Kasahara, K., Nakajima, H. and Adachi, M. (2002) Structural changes of the airway wall impair respiratory function, even in mild asthma. Chest 122, 1622-1626
38. Ward, C., Johns, D. P., Bish, R., Pais, M., Reid, D. W., Ingram, C., Feltis, B. and Walters, E. H. (2001) Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am. J. Respir. Crit. Care Med. 164, 1718-1721
39. Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T. K., Cochran, R., DeMartino, S., Schechtman, K. B., Hussain, I., Holtzman, M. J. and Castro, M. (2007) Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am. J. Respir. Crit. Care Med. 176, 138-145
40. Broekema, M., ten Hacken, N. H., Volbeda, F., Lodewijk, M. E., Hylkema, M. N., Postma, D. S. and Timens, W. (2009) Airway epithelial changes in smokers but not in ex-smokers with asthma. Am. J. Respir. Crit. Care Med. 180, 1170-1178
41. Royce, S. G., Tan, L., Koek, A. A. and Tang, M. L. (2009) Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma. Ann. Allergy Asthma Immunol. 102, 238-246
42. Wilson, J. W., Li, X. and Pain, M. C. (1993) The lack of distensibility of asthmatic airways. Am. Rev. Respir. Dis. 148, 806-809
43. Wiggs, B. R., Bosken, C., Pare, P. D., James, A. and Hogg, J. C. (1992) A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145, 1251-1258
44. Garibay-Tupas, J. L., Okazaki, K. J., Tashima, L. S., Yamamoto, S. and Bryant-Greenwood, G. D. (2004) Regulation of the human relaxin genes H1 and H2 by steroid hormones. Mol. Cell. Endocrinol. 219, 115-125
45. Halls, M. L., Bathgate, R. A. and Summers, R. J. (2007) Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes. J. Pharmacol. Exp. Ther. 320, 281-290
46. Degen, M., Goulet, S., Ferralli, J., Roth, M., Tamm, M. and Chiquet-Ehrismann, R. (2009) Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblast. Clin. Exp. Allergy 39, 688-699
47. Silvestri, M., Sabatini, F., Scarso, L., Cordone, A., Dasic, G. and Rossi, G. (2002) Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int. Arch. Allergy Immunol. 128, 51-58
48. Mattos, W., Lim, S., Russell, R., Jatakanon, A., Chung, K. F. and Barnes, P. J. (2002) Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 122, 1543-1552
49. Herbert, C., Hettiaratchi, A., Webb, D. C., Thomas, P. S., Foster, P. S. and Kumar, R. K. (2008) Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin. Exp. Allergy 38, 847-856
50. McMillan, S. J., Xanthou, G. and Lloyd, C. M. (2005) Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin. Exp. Allergy 35, 388-396
51. Vanacker, N., Palmans, E., Kips, J. and Pauwels, R. (2001) Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am. J. Respir. Cell Mol. Biol. 163, 674-879
52. Kelly, E. A. B., Busse, W. W. and Jarjour, N. N. (2000) Inhaled Budesonide decreases airway inflammatory response to allergen. Am. J. Respir. Crit. Care Med. 162, 883-890
53. Olivieri, D., Chetta, A., Donno, M. D., Bertorelli, G., Casalini, A., Pesci, A., Testi, R. and Foresi, A. (1997) Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am. J. Respir. Crit. Care Med. 6, 1864-1871
54. Jeffery, P. K., Godfrey, R., Adelroth, E., Nelson, F., Rogers, A. and Johansson, S. (1992) Effects of treatment on airway inflammation and thickening basement membrane reticular collagen in asthma: a quantitative light and electron microscopy study. Am. Rev. Respir. Dis. 145, 890-899
55. Tanaka, H., Matsuda, T., Tokuoka, S., Takahashi, Y., Komai, M., Nagao, K. and Nagai, H. (2002) Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling. Inflamm. Res. 51, 307-316
56. Yamauchi, K. and Inoue, H. (2007) Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol. Int. 56, 321-329
57. Hoshino, M. (2004) Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling Clin. Rev. Allergy Immunol. 27, 59-64
58. Laitinen, A., Altraja, A., Kampe, M., Linden, M., Virtanen, I. and Laitinen, L. A. (1997) Tenascin is increased in airway basement membrane of asthmatic and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 156, 951-958
59. Ward, C., Pais, M., Bish, R., Reid, D., Feltis, B., Johns, D. and Walters, E. H. (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57, 309-316
60. Korn, S., Wouters, E., Wesseling, G., Arends, J. and Thunnissen, F. (1997) In vitro and in vivo modulation of α- and γ-glucocorticoid receptor mRNA in human bronchial epithelium. Am. J. Respir. Crit. Care Med. 155, 1117-1122